Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRONG: Strontium Ranelate for Radiological Healing of Proximal Femur Fractures
NCT05712616Phase 4Unknown
- Sponsor
- Aga Khan University Hospital
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of strontium ranelate in Femur fracture (2 arms), sponsored by Aga Khan University Hospital. Primary endpoint: Change in Radiological healing on radiographs at 24 weeks. Status: unknown.
02
Drugs
strontium ranelate
03
Conditions
Femur fracture
Beyond the preview
Go deeper on NCT05712616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712616.